Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

T
Tabatabaeian Nimavardi, Ali

Certara UK (Simcyp Division)
(M1430-07-40) Mechanistic PBPK Modelling of Itraconazole Oral Solutions: Evaluating HP-β-CD Impact on Solubility and Drug-Drug Interactions
Ali Tabatabaeian Nimavardi
Favorite
Tachibana, Tatsuhiko

Chugai Pharmaceutical Co., Ltd.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Tatsuhiko Tachibana
Favorite
Tadjiki, Soheyl

Postnova Analytics
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Soheyl Tadjiki
Favorite
Taft, David

Long Island University
(T0930-02-12) A PBPK Model to Simulate Intranasal Naloxone Rescue from Fentanyl Overdose
David Taft
Favorite
(T1330-02-11) A PBPK Model for Acetaminophen: Incorporation of SULT Enzyme Ontogeny to Predict Age-Dependent Metabolism and Systemic Exposure in Pediatric Patient Populations
David Taft
Favorite
Taha, Iman

University of Mississippi
(T0930-04-20) Effect of Processing Method on Release Profile of Fenofibrate Amorphous Solid Dispersion Prepared by Hot Melt Extrusion and 3D Printing
Iman Taha
Favorite
(T1530-01-03) Influence of Composition Variation on Solubility and Release Profile of CBD Self-Emulsifying Drug Delivery System
Iman Taha
Favorite
(W1230-03-17) Optimizing the Process Parameters for Utilizing Hot-Melt Extrusion Technology in the Development of Cannabidiol Nano-Structured Lipid Carriers
Iman Taha
Favorite
Tahara, Kohei

Gifu Pharmaceutical University
(T1330-10-56) Development of Inhaled Dry Powder Using Electrospinning Method
Kohei Tahara
Favorite
Taherian, Elham

University of Iowa
(W1230-11-64) A Comparative Study of Agitation-Induced Aggregation of Monoclonal Antibodies via Horizontal Shaking and Orbital Shaking
Elham Taherian
Favorite
Tajarobi, Pirjo

AstraZeneca
(W0930-09-51) Evaluating Formulation Platforms for Poorly Soluble APIs to Mimic PROTACs
Pirjo Tajarobi
Favorite
Takagi, Ayaka

Osaka Medical and Pharmaceutical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Ayaka Takagi
Favorite
Takechi-Haraya, Yuki

National Institute of Health Sciences
(T1530-04-23) Constitution of a Helical Peptide on Exosome-Mimetic Vesicles
Yuki Takechi-Haraya
Favorite
Takeda, Hideo

Physio Mckina Co., Ltd.
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Hideo Takeda
Favorite
(M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
Hideo Takeda
Favorite
(T1430-05-25) Monitoring the Dissolution Behavior of Dissolving Microneedles by UV-Vis Imaging System
Hideo Takeda
Favorite
(W1030-09-52) Development of L-dopa-Loaded Nanofiber for Transbuccal Drug Delivery
Hideo Takeda
Favorite
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Hideo Takeda
Favorite
Takeuchi, Katsuyuki

Tokyo Medical and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Katsuyuki Takeuchi
Favorite
Talluri, Sesha Rajeswari

Rutgers, The State University of New Jersey
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Sesha Rajeswari Talluri
Favorite
(T1430-01-06) Preparation and Characterization of Diclofenac Loaded Polymeric Nanoparticles from Mango Seed Kernel Starch
Sesha Rajeswari Talluri
Favorite
Talmadge, James E.

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
James E. Talmadge
Favorite
Tamam, Hassan

Purdue University
(T1030-10-54) Development of Dual-Ligand Nanoparticles for Systemic Chemoimmunotherapy of Cancer
Hassan Tamam
Favorite
Tamanna, Tasmi

North South University
(W0930-01-03) Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study
Tasmi Tamanna
Favorite
Tamashiro, Shintaro

Gifu Pharmaceutical University
(T1330-10-56) Development of Inhaled Dry Powder Using Electrospinning Method
Shintaro Tamashiro
Favorite
Tamhane, Mitalee

AbbVie Inc.
(M1030-02-07) Review of First-in-Human Trials for Gene Therapy in Ocular Diseases
Mitalee Tamhane
Favorite
Tanai, Ikuo

Freund Corporation
(T1430-10-59) Enhanced Versatility of a Novel Coating Methods of Fine Particles for Time-Saving
Ikuo Tanai
Favorite
Tanaka, Mayuko

Physio Mckina Co., Ltd.
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Mayuko Tanaka
Favorite
Tanaka, Yurika

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Yurika Tanaka
Favorite
Tang, Andrew

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Andrew Tang
Favorite
Tang, Michelle

Regeneron Pharmaceuticals
(M1130-05-27) Evaluating the Efficacy of Polyoxyethylene Sorbitan as a Novel Surfactant in Biotherapeutic Antibody Formulations
Michelle Tang
Favorite
Tang, Tiffany

Merck Sharp & Dohme Corp.
(T1430-06-32) High Throughput N-glycan Analysis of Heavily Glycosylated Protein Therapeutics to Support Real-Time %sialylation Monitoring for Upstream Bioreactors
Tiffany Tang
Favorite
Tang, Xiaojia

Mayo Clinic
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Xiaojia Tang
Favorite
Tang, Yongan

AbbVie Inc.
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Yongan Tang
Favorite
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Yongan Tang
Favorite
Tank, Shivali

Vivekanand Education Society’s College of Pharmacy
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Shivali Tank
Favorite
Tanna, Nikunj

Waters Corporation
(T1230-04-24) SPE-LC/MS Bioanalytical Quantification of the Biotherapeutic Peptide, Semaglutide from Plasma
Nikunj Tanna
Favorite
Tanner, Eden

University of Mississippi
(W1130-03-17) Re-engineering of Lipid Nanoparticles Using Ionic Liquids for Brain Drug Delivery
Eden Tanner
Favorite
Tao, Xun

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Xun Tao
Favorite
Tao, Yi

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Yi Tao
Favorite
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Yi Tao
Favorite
Tao, Yushi

Queen's University Belfast
(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
Yushi Tao
Favorite
Tarczynski, Frank

Alcami Corporation
(M1230-04-19) Guaifenesin: Discovery and Attributes of Novel Racemic Compound
Frank Tarczynski
Favorite
(W0930-11-62) Quantification of Novel Racemic Compound of Guaifenesin in Commercial Conglomerate Material Using Powder X-ray Diffraction
Frank Tarczynski
Favorite
Ta, Stephan

Zerion A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Stephan Ta
Favorite
Tatum, Wesley

Seran Bioscience
(M1330-07-41) Manufacturing and Formulation Impacts on Colloidal Speciation in ASD Dosage Forms
Wesley Tatum
Favorite
Tavares, Francisco

Hovione
(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability
Francisco Tavares
Favorite
(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking
Francisco Tavares
Favorite
Tawde, Salonee

University of Maryland Baltimore
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Salonee Tawde
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Salonee Tawde
Favorite
Tawde, Suprita

Nexus Pharmaceuticals LLC
(M1530-09-51) Influence of Lyophilization Process Conditions on Crystallization Behavior and Formulation Stability of Doxycycline for Injection
Suprita Tawde
Favorite
Tayade, Nitin

Colorcon Asia Pvt Ltd
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Nitin Tayade
Favorite
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Nitin Tayade
Favorite
Taylor, Lynne

Purdue University
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Lynne Taylor
Favorite
(M1330-07-38) Proof of Concept In Situ Salt Formation during Amorphous Solid Dispersion Fabrication to Improve Physical Stability and Drug Release Performance
Lynne Taylor
Favorite
Taylor, Melissa

Moderna Therapeutics
(T0930-06-33) Troubleshooting the Lack of Neutralizing Antibody Activity during Development of an Enzyme-Based nAb Assay
Melissa Taylor
Favorite
Taylor, Nicole

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Nicole Taylor
Favorite
Telaprolu, Krishna Chaitanya

Certara UK (Simcyp Division)
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Krishna Chaitanya Telaprolu
Favorite
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Krishna Chaitanya Telaprolu
Favorite
(W1130-02-07) Development and Verification of a Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Progesterone Ring and Gel Formulations
Krishna Chaitanya Telaprolu
Favorite
Teleshova, Natalia

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Natalia Teleshova
Favorite
Temkitthawon, Prapapan

Naresuan University
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Prapapan Temkitthawon
Favorite
Tennimier, David

SCIEX
(T1330-06-33) Ultra-High Throughput HILIC-Free Analysis of Oligonucleotides Using Acoustic Ejection Mass Spectrometry
David Tennimier
Favorite
Terao, Kimio

Chugai Pharmaceutical Co., Ltd.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Kimio Terao
Favorite
Terpak, Nicole

Vantage Specialty Chemicals
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Nicole Terpak
Favorite
Terry, David

Foghorn Therapeutics
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
David Terry
Favorite
Teska, Jordan

Freund Inc.
(M1430-10-54) Designing Spray Dried Particles with a Pressure Nozzle at Small Scale
Jordan Teska
Favorite
Thakker, Prashant

Colorcon Asia Pvt Ltd
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Prashant Thakker
Favorite
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Prashant Thakker
Favorite
Thakur, Kanika

Certara UK (Simcyp Division)
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Kanika Thakur
Favorite
(W1130-02-07) Development and Verification of a Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Progesterone Ring and Gel Formulations
Kanika Thakur
Favorite
Theisen, Robert

Colorcon, Inc.
(T1230-01-02) Effect of Mixing Time and Mixing Process on Lubricant Sensitivity of Excipients with Different Deformation Characteristics
Robert Theisen
Favorite
Thomas, Anitha

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Anitha Thomas
Favorite
(W1230-09-51) A Mucoadhesive Composition for Pulmonary Delivery of mRNA Lipid Nanoparticles
Anitha Thomas
Favorite
Thomas, Heath

Aclairo
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
Heath Thomas
Favorite
Thomas, Sherin

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Sherin Thomas
Favorite
Thomas, Vidhya

Kuwait University
(T1230-04-22) Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Vidhya Thomas
Favorite
Thombre, Ruchi

Pfizer Inc.
(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form
Ruchi Thombre
Favorite
Thompson, Kevin

Mayo Clinic
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Kevin Thompson
Favorite
Thompson, Walter

Eastman
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Walter Thompson
Favorite
Thongsukmak, Atsawin

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Atsawin Thongsukmak
Favorite
Thorne, Christopher

Thermo Fisher Scientific
(T1230-11-64) Roller Compaction Simulation Reproducible Milling Technologies Between Lab Scale and Pilote Scale
Christopher Thorne
Favorite
(T1530-11-64) A Rational Approach to Scaling-Up Lubrication in Pharmaceutical Tablet Manufacturing
Christopher Thorne
Favorite
(W0930-11-60) Case Study Approach of an Excipient Compaction Assessment to Support Dual Sourcing
Christopher Thorne
Favorite
Thorne, Pascal

Thermo Fisher Scientific
(T1230-11-64) Roller Compaction Simulation Reproducible Milling Technologies Between Lab Scale and Pilote Scale
Pascal Thorne
Favorite
(W0930-11-60) Case Study Approach of an Excipient Compaction Assessment to Support Dual Sourcing
Pascal Thorne
Favorite
Thorne, Peter

University of Iowa
(T0930-09-48) Cationic CaMKIIN-Loaded Liposomes that Reduce Chlorine-Induced Airway Oxidative Stress
Peter Thorne
Favorite
Thorsteinsson, Thorsteinn

Avadel
(M1430-01-02) Mixture of Immediate-Release Beads and Controlled-Release Beads to Form Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)
Thorsteinn Thorsteinsson
Favorite
(M1530-01-02) 2-Stage Dissolution Method for Drug Release Testing of Sodium Oxybate Extended-Release Drug Product LUMRYZ^TM
Thorsteinn Thorsteinsson
Favorite
(T0930-07-40) Soft Foods as Alternative Reconstitution Vehicles for Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)
Thorsteinn Thorsteinsson
Favorite
Thota, Sunil kumar

Irma Lerma Rangel School of Pharmacy
(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate
Sunil kumar Thota
Favorite
Tian, Lei

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Lei Tian
Favorite
Tian, Li

US Food and Drug Administration
(M1330-11-61) Performance Verification Variations Within Mechanical Calibration Allowance of Paddle Apparatus with Standard and Apex Vessels
Li Tian
Favorite
Tian, Shiying

Adare Pharma Solutions
(W1030-10-57) The Effect of Food Vehicle on In Vitro Performance of Mini-Tablets Formulation
Shiying Tian
Favorite
(W1030-10-59) Optimization of Assay Method for a Drug with Two pKa
Shiying Tian
Favorite
Tian, Wei

Zerion A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Wei Tian
Favorite
Tiesman, Daniel

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Daniel Tiesman
Favorite
Tijani, Akeemat

East Tennessee State University
(T1130-01-06) Nystatin-Loaded Microneedles via MeltPreP Vacuum Compression Molding for Prolonged Defense Against Candida albicans
Akeemat Tijani
Favorite
(W0930-05-29) Comparative Study of Mold Casting and Vacuum Compression Molding Techniques for Fabricating Drug-Loaded Microneedle Arrays: Precision, Drug Loading, and Performance Evaluation
Akeemat Tijani
Favorite
Titus, Celene

University of Toronto
(M1530-04-22) Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders
Celene Titus
Favorite
Tiwari, Deo

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Deo Tiwari
Favorite
Tiwari, Sandip

BASF Corporation
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Sandip Tiwari
Favorite
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Sandip Tiwari
Favorite
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Sandip Tiwari
Favorite
(T0930-10-59) In Vitro and In Vivo Correlations of Danazol-SEDDS Formulations Using MacroFLUX^TM and miniFLUX™
Sandip Tiwari
Favorite
(T1030-09-49) Analyzing the Characteristics of HME Extruded Material in Pharmaceutical 3D Printing: Formulation, Printability, and Dissolution Study
Sandip Tiwari
Favorite
(T1330-04-19) Non-Gelatin Film Coatings for Formulating Easy-to-Swallow Tablets
Sandip Tiwari
Favorite
(T1430-02-11) Alcohol Dose Dumping in Modified Release Formulations: Critical Considerations for Regulatory Guidance(s)
Sandip Tiwari
Favorite
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
Sandip Tiwari
Favorite
(W1030-10-55) Optimizing Tablet Formulation through Integrated Use of Digital Formulation Tools and Compaction Simulation
Sandip Tiwari
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Sandip Tiwari
Favorite
Tobin, Kevin

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Kevin Tobin
Favorite
Tocce, Elizabeth

International Flavors and Fragrances
(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature
Elizabeth Tocce
Favorite
(W1130-10-55) Improving Sensitivity and Accuracy in Nitrite Measurement in Hydroxypropyl Methylcellulose
Elizabeth Tocce
Favorite
To, Daniel

Colorcon, Inc.
(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets
Daniel To
Favorite
(T1330-11-65) Considerations for Drug layering of Sitagliptin on Placebo Tablets to Manufacture Fixed Dose Combination Drug Products
Daniel To
Favorite
Todd, Paula

International Flavors and Fragrances
(T1030-03-13) The Selection of Microcrystalline Cellulose Based Excipient in Extrusion Spheronization
Paula Todd
Favorite
To, Kenneth K.W.

Chinese University of Hong Kong, The
(M1530-02-11) Circumvention of Targeted Anticancer Drug Resistance by Standardized Yunzhi Extract
Kenneth K.W. To
Favorite
Tomarchio, Aaron

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Aaron Tomarchio
Favorite
Tomassen, Peter

Ghent University
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Peter Tomassen
Favorite
Tomezyk, Aurore

Aliri Bioanalysis
(M1330-06-32) Quantifying and Mapping ATP Distribution Within Tissues to Inform Targeted Therapeutic Strategies in Drug Development
Aurore Tomezyk
Favorite
Tomita, Dianne

BioCryst
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Dianne Tomita
Favorite
Tomono, Takumi

Setsunan University
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Takumi Tomono
Favorite
Tong, Anqi

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Anqi Tong
Favorite
Tong, Rong

Virginia Polytechnic Institute and State University
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Rong Tong
Favorite
Tong, Sharon

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Sharon Tong
Favorite
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Sharon Tong
Favorite
Topp, Elizabeth

Purdue University
(W1230-11-65) Effect of Lyophilization Process Parameters on the Stability of mRNA Lipid Nanoparticles (LNP)
Elizabeth Topp
Favorite
Torchilin, Vladimir P.

Northeastern University
(T1230-01-01) Exploring Rifamycin Cytotoxic Potential in 2D and 3D Cancer Cell Models Using Liposomes as Delivery System
Vladimir P. Torchilin
Favorite
Torres, Alex

Evonik Canada, Inc.
(M0930-09-51) Improvements in Liposomal Manufacturing Technology
Alex Torres
Favorite
Torre, Sandra Dela

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Sandra Dela Torre
Favorite
Torres, Pedro

Universidad de Chile
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Pedro Torres
Favorite
Tortoles, Daphne

NanoImaging Services
(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing
Daphne Tortoles
Favorite
Tounge, Brett

Mebias Discovery, Inc.
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Brett Tounge
Favorite
(W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
Brett Tounge
Favorite
Tousi, Fatemeh

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Fatemeh Tousi
Favorite
Tower, Cole

Purdue University
(M0930-11-60) Improving the Stability of RNA Lipid Nanoparticles Using the Innovative Spray-Freeze Drying Technique
Cole Tower
Favorite
(T1130-11-60) Investigating the Impact of Drying Processes on RNA Lipid Nanoparticles
Cole Tower
Favorite
Tozuka, Yuichi

Osaka Medical and Pharmaceutical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Yuichi Tozuka
Favorite
(M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
Yuichi Tozuka
Favorite
Trampont, Paul

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Paul Trampont
Favorite
(M1330-02-12) Multi-Strain Sars-Cov-2 Neutralization Assay Qualification
Paul Trampont
Favorite
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Paul Trampont
Favorite
Trapa, Patrick

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Patrick Trapa
Favorite
Treffer, Daniel

MeltPrep GmbH
(T1130-01-06) Nystatin-Loaded Microneedles via MeltPreP Vacuum Compression Molding for Prolonged Defense Against Candida albicans
Daniel Treffer
Favorite
(W0930-05-29) Comparative Study of Mold Casting and Vacuum Compression Molding Techniques for Fabricating Drug-Loaded Microneedle Arrays: Precision, Drug Loading, and Performance Evaluation
Daniel Treffer
Favorite
Trinh, Duong N.

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Duong N. Trinh
Favorite
Trinh, Jamie

University of Connecticut
(T1030-01-05) Development of Modality-Agnostic Strategies for High Concentration Biologic Candidate Selection
Jamie Trinh
Favorite
Trippier, Paul

University of Nebraska Medical Center
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Paul Trippier
Favorite
Trivedi, Maitri Chetan

Mercer University
(M1530-07-41) Preparation and Characterization of Hydrogel Microneedles Using Gantrez®S-97 and Hyaluronic Acid
Maitri Chetan Trivedi
Favorite
(M1530-07-41) Preparation and Characterization of Hydrogel Microneedles Using Gantrez®S-97 and Hyaluronic Acid
Maitri Chetan Trivedi
Favorite
Trivedi, Meghana

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Meghana Trivedi
Favorite
Trivedi, Riddhi

North Dakota State University
(M1430-03-17) Targeted Antiretroviral Therapy Using Controlled Release Polymeric Nanoparticles for Brain Viral Load Reduction and Management of HIV Associated Neurocognitive Disorder (HAND)
Riddhi Trivedi
Favorite
(T1230-05-30) Controlled Release Mannose and RVG-9R Functionalized PLGA Nanoparticles for Targeting the Brain Viral Reservoir for the Management of HIV Associated Neurocognitive Disorder
Riddhi Trivedi
Favorite
Trommeshauser, dirk

Boehringer Ingelheim
(M1530-10-55) Using Dissolution-Permeation Systems and In Silico PBPK Modeling for Food Effect Prediction of a BCS Class II Drug
dirk Trommeshauser
Favorite
Troth, Emma

SomaLogic
(M0930-10-54) Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
Emma Troth
Favorite
Trudeau, Mary

Waters Corporation
(T1230-04-24) SPE-LC/MS Bioanalytical Quantification of the Biotherapeutic Peptide, Semaglutide from Plasma
Mary Trudeau
Favorite
Trujeque, Damien

University of Colorado
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Damien Trujeque
Favorite
Trujillo, Adriana

NanoImaging Services
(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing
Adriana Trujillo
Favorite
Tsakalozou, Eleftheria

US Food and Drug Administration
(M1430-01-06) Formulation Effects of Marketed Oral Cavity Products on In Vitro Buccal Permeability
Eleftheria Tsakalozou
Favorite
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
Eleftheria Tsakalozou
Favorite
(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel
Eleftheria Tsakalozou
Favorite
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Eleftheria Tsakalozou
Favorite
(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa
Eleftheria Tsakalozou
Favorite
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Eleftheria Tsakalozou
Favorite
Tseng, Chien-Te Kent

University of Texas Medical Branch
(M1430-04-22) Discovery and Development of a New Therapeutic Product for the Treatment Long Covid
Chien-Te Kent Tseng
Favorite
Tseng, Yin-Chao

Boehringer Ingelheim Pharmaceuticals, Inc.
(T0930-11-65) Quantitative Prediction of Segregation Risk in Multicomponent Pharmaceutical Blends
Yin-Chao Tseng
Favorite
(T1130-01-02) Application of Knowledge Based Expert System to Predict API-Excipient Incompatibilities
Yin-Chao Tseng
Favorite
(W1230-01-04) A Hybrid Mechanistic Model for Predicting Milling Performance of Roller Compacted Ribbons
Yin-Chao Tseng
Favorite
Tsinman, Oksana

Pion Inc.
(T0930-10-59) In Vitro and In Vivo Correlations of Danazol-SEDDS Formulations Using MacroFLUX^TM and miniFLUX™
Oksana Tsinman
Favorite
Tsuji, Takanobu

Dalton Corporation
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Takanobu Tsuji
Favorite
Tsume, Yasuhiro

Merck & Co., Inc.
(W1130-02-10) The Advantage and Disadvantage of In Vivo Predictive Dissolution Profiles of BCS Class II Drugs Generated by a Transfer Method and Compendial Method with Different Buffer Species
Yasuhiro Tsume
Favorite
Tsuru, Kyosuke

Asahi Kasei Corporation
(M1330-10-56) Comparative Study of Suitability for Wet Continuous Manufacturing Process Using MCC with Different Characteristics - Part 2
Kyosuke Tsuru
Favorite
Tsutsumi-Ogawa, Shiho

University of Tsukuba
(T1530-04-23) Constitution of a Helical Peptide on Exosome-Mimetic Vesicles
Shiho Tsutsumi-Ogawa
Favorite
Tsutsumi, Yasuhiro

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Yasuhiro Tsutsumi
Favorite
Tubbs, Josiah

Celerion
(W1030-06-34) Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Josiah Tubbs
Favorite
Tu, Buu

Saint Joseph's University
(W1030-03-17) Amorphous Stabilization of BCS II Drugs Using Mesoporous Silica
Buu Tu
Favorite
Tuhin, Md Tariqul Haque

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Md Tariqul Haque Tuhin
Favorite
Tuliani, Vinod

Roquette America Inc.
(M1530-07-40) Mannitol vs Lactose in Twin Screw Continuous Wet Granulation Using New Binder
Vinod Tuliani
Favorite
(T1030-07-40) New Direct Compressible Mannitol for Minitablets Industrial Scale Manufacturing
Vinod Tuliani
Favorite
(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets
Vinod Tuliani
Favorite
(T1530-07-37) Direct Compression and Continuous Wet Granulation for Controlled Release Minitablets
Vinod Tuliani
Favorite
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Vinod Tuliani
Favorite
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Vinod Tuliani
Favorite
Tunc, Cansu

University of Utah
(M1430-03-13) Combination eEF2K Gene and Drug Delivery for Treatment of Breast Cancer
Cansu Tunc
Favorite
(T0930-02-08) The Influence of Silica Nanoparticles with Varied Physicochemical Properties on the Immune Function of RAW 264.7 Macrophages
Cansu Tunc
Favorite
Turin, Rachel

Drake University
(T1230-11-65) Epinephrine Degradation in Pediatric Auto-Injectors
Rachel Turin
Favorite
Turner, Brenden

GlaxoSmithKline plc
(M1130-07-38) An Assessment of Factors Influencing the Integrity of Sprayed-On Silicone Oil Layer in Prefilled Syringes and Functionality of Prefilled Syringes
Brenden Turner
Favorite
Turner, David

Certara UK Ltd.
(M1430-07-40) Mechanistic PBPK Modelling of Itraconazole Oral Solutions: Evaluating HP-β-CD Impact on Solubility and Drug-Drug Interactions
David Turner
Favorite
(W1130-02-12) Virtual Bioequivalence (VBE) Outcome May Depend on Choice of Dissolution Inputs in Physiologically Based Pharmacokinetic Modelling
David Turner
Favorite
Tushakiran, Mallika

Contract Pharmaceuticals Limited
(T1430-11-65) Unraveling the Impact of Polymeric Material Attributes in Semisolid Products: Paving the Way for Consistent Viscosity Profile Across Commercial Batches
Mallika Tushakiran
Favorite
Tuvin, Daniel

Sanford Health
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Daniel Tuvin
Favorite
Tzul, Franco

Regeneron Pharmaceuticals
(M1130-05-27) Evaluating the Efficacy of Polyoxyethylene Sorbitan as a Novel Surfactant in Biotherapeutic Antibody Formulations
Franco Tzul
Favorite